Is Premenstrual Dysphoric Disorder hereditary?

Premenstrual Dysphoric Disorder (PMDD) is considered a complex, multifactorial condition rather than a simple hereditary disease caused by a single gene mutation.

Understanding the Genetic Component

While Premenstrual Dysphoric Disorder is not "hereditary" in the sense of following classic Mendelian inheritance patterns (like autosomal dominant or recessive), research strongly indicates a significant genetic predisposition. Studies, including twin studies, suggest that the heritability of Premenstrual Dysphoric Disorder symptoms ranges between 30% and 80%. This means that while genetics create a vulnerability, environmental factors and the individual’s unique sensitivity to hormonal fluctuations play a crucial role in the expression of the disease.

Inheritance and Risk

Because Premenstrual Dysphoric Disorder is multifactorial, there is no specific risk percentage for children of an affected parent. It is not caused by a single de novo mutation, nor is it X-linked or mitochondrial. Instead, it involves an interplay of multiple genes—likely those regulating neurotransmitter sensitivity (such as serotonin) and hormonal receptors—interacting with the endocrine system. Because the condition is not caused by a single identifiable gene, there is no clinical genetic testing available to diagnose Premenstrual Dysphoric Disorder or to predict its occurrence in offspring.

The Role of Genetic Counseling

Genetic counseling for Premenstrual Dysphoric Disorder is less about predicting inheritance and more about supporting families in understanding the biological nature of the condition. If you are planning a pregnancy, a counselor can help you manage expectations regarding the impact of hormonal changes on your mood and physical well-being. Since we cannot perform carrier testing or prenatal diagnosis for this condition, our focus remains on clinical management through lifestyle, hormonal therapies, and psychological support. Understanding that the disorder is a biological reality, rather than a personal failing, is often the most important outcome for families navigating the impact of the disease.

Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• National Institutes of Health (NIH) - National Institute of Mental Health (NIMH)


• International Association for Premenstrual Disorders (IAPMD)